These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30689936)

  • 41. Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish.
    Lu JW; Yang WY; Lin YM; Jin SL; Yuh CH
    Acta Histochem; 2013 Sep; 115(7):728-39. PubMed ID: 23499292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
    Yoshioka Y; Hashimoto E; Yatsuji S; Kaneda H; Taniai M; Tokushige K; Shiratori K
    J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.
    Piccioni F; Malvicini M; Garcia MG; Rodriguez A; Atorrasagasti C; Kippes N; Piedra Buena IT; Rizzo MM; Bayo J; Aquino J; Viola M; Passi A; Alaniz L; Mazzolini G
    Glycobiology; 2012 Mar; 22(3):400-10. PubMed ID: 22038477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study.
    Yeh MM; Liu Y; Torbenson M
    Hum Pathol; 2015 Nov; 46(11):1769-75. PubMed ID: 26410018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma.
    de Lima VM; Oliveira CP; Alves VA; Chammas MC; Oliveira EP; Stefano JT; de Mello ES; Cerri GG; Carrilho FJ; Caldwell SH
    J Hepatol; 2008 Dec; 49(6):1055-61. PubMed ID: 18929425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyaluronan Rich Microenvironment in the Limbal Stem Cell Niche Regulates Limbal Stem Cell Differentiation.
    Gesteira TF; Sun M; Coulson-Thomas YM; Yamaguchi Y; Yeh LK; Hascall V; Coulson-Thomas VJ
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4407-4421. PubMed ID: 28863216
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.
    Lackner C
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):223-31. PubMed ID: 21476917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyaluronan Production by Renomedullary Interstitial Cells: Influence of Endothelin, Angiotensin II and Vasopressin.
    Stridh S; Palm F; Takahashi T; Ikegami-Kawai M; Friederich-Persson M; Hansell P
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.
    Pittala S; Krelin Y; Shoshan-Barmatz V
    Neoplasia; 2018 Jun; 20(6):594-609. PubMed ID: 29747160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extensive CD44-dependent hyaluronan coats on human bone marrow-derived mesenchymal stem cells produced by hyaluronan synthases HAS1, HAS2 and HAS3.
    Qu C; Rilla K; Tammi R; Tammi M; Kröger H; Lammi MJ
    Int J Biochem Cell Biol; 2014 Mar; 48():45-54. PubMed ID: 24406795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival.
    Auvinen P; Rilla K; Tumelius R; Tammi M; Sironen R; Soini Y; Kosma VM; Mannermaa A; Viikari J; Tammi R
    Breast Cancer Res Treat; 2014 Jan; 143(2):277-86. PubMed ID: 24337597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genomic aspects of NAFLD pathogenesis.
    Naik A; Košir R; Rozman D
    Genomics; 2013 Aug; 102(2):84-95. PubMed ID: 23545492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyaluronic acid inhibition by 4-methylumbelliferone reduces the expression of cancer stem cells markers during hepatocarcinogenesis.
    Sukowati CHC; Anfuso B; Fiore E; Ie SI; Raseni A; Vascotto F; Avellini C; Mazzolini G; Tiribelli C
    Sci Rep; 2019 Mar; 9(1):4026. PubMed ID: 30858465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Natural Course of Non-Alcoholic Fatty Liver Disease.
    Calzadilla Bertot L; Adams LA
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin-like growth factor I receptor β expression in hepatocellular carcinoma.
    Liu X; Jiang W; Aucejo F; Kim R; Miller C; Byrne M; Lopez R; Yerian L
    Hum Pathol; 2011 Jun; 42(6):882-91. PubMed ID: 21292299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of hyaluronan synthases upregulated by thyroid hormone is involved in intestinal stem cell development during Xenopus laevis metamorphosis.
    Fujimoto K; Hasebe T; Kajita M; Ishizuya-Oka A
    Dev Genes Evol; 2018 Dec; 228(6):267-273. PubMed ID: 30430240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India.
    Jain D; Nayak NC; Kumaran V; Saigal S
    Arch Pathol Lab Med; 2013 Jul; 137(7):961-6. PubMed ID: 23808468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?
    Cotrim HP; Paraná R; Braga E; Lyra L
    Am J Gastroenterol; 2000 Oct; 95(10):3018-9. PubMed ID: 11051414
    [No Abstract]   [Full Text] [Related]  

  • 59. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.
    Kishida N; Matsuda S; Itano O; Shinoda M; Kitago M; Yagi H; Abe Y; Hibi T; Masugi Y; Aiura K; Sakamoto M; Kitagawa Y
    BMC Gastroenterol; 2016 Jun; 16(1):61. PubMed ID: 27296438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histologically proven hepatocellular carcinoma associated with burned-out nonalcoholic steatohepatitis.
    Kaneda K; Uenishi T; Takemura S; Yamamoto T; Sakata C; Sakae M; Urata Y; Ohata K; Tanaka S; Wakasa K; Kubo S
    Osaka City Med J; 2013 Dec; 59(2):99-104. PubMed ID: 24575585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.